Search Results
Results found for "Stuart Maudsley"
- From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry
But Sokhom’s journey started differently.
- Innovative Data-Driven Solutions: The pHSense Revolution
What started as a chemistry problem has evolved into a discovery platform. “You start wide with chemistry, you narrow with biology, and at the end—if you did it right—you open
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
Watch Episode 167 What started with a single receptor became a toolset for an entire superfamily.
- Ben Clements on Rescuing Opioids with GPCR Modulators
Start learning with our GPCR University today. _______________ Keyword Cloud: GPCR research community
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Get ahead, stay relevant, and lead—starting today. The Dr. GPCR Team Read Full Edition ➤
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
personal pain can lead to professional purpose — and why the next generation of pain researchers needs to start
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
This Week’s GPCR Intelligence: If you want cleaner decisions, start with the system—then the ligand. GPCR Podcast Starting next week, new episodes will drop bi-weekly on Wednesday mornings — giving you
- The Truth About GPCR Product Launches: Years in the Making
Eric Trinquet The Real Work Starts Before the Lab What most scientists don’t see is how long a product It started not with biology—but with chemistry. Revvity and academic collaborator Prof.
- Mapping Motion: Intermediate States, Deorphanization & Discovery
GPCR Colleagues & Curiosity-Driven Minds, We’re starting with exciting Dr.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
the extracellular binding site of the GPCR, the protein changes into its active conformation , which starts to study therapeutic targets are fluorescent ligands , which are very useful in GPCR drug discovery, starting
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
schools and universities, research centers, governmental institutions, or private companies) Deadlines Start
- From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry
From Empty Lab to GPCR Discovery Starting in an empty lab with just a shared desk, Alessandro and Antonella
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
study will evaluate TRV045 safety, tolerability, and PK in healthy volunteers Enrollment expected to start
- 📰 GPCR Weekly News - January 2 to 8, 2023
Industry News Arcoscreen selected by START Lausanne to pitch at the START Global summit on the 23-24th
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
Starting from a high-throughput screening hit, we describe the iterative optimization of a chemical series
- Advantages of Fluorescent Probes in GPCR Assays
fluorescent antagonist (CELT-327) was added to HCT116 cells (colon cancer cell line), detectable fluorescence starting for GPCR assays using Fluorescent Probes The preparation of the cellular system is the most common starting
- Pharmacology at Your Fingertips: Terry’s Corner Launches
To start receiving our newsletter in your inbox every Thursday, follow these simple steps: Select the
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Starting from previously reported intracellular CCR2 antagonists, several tetramethylrhodamine (TAMRA
- 📰 GPCR Weekly News, March 11 to 17, 2024
Simply fill out this form to get started! Are you free for a few minutes? GPCR University Save the date for our upcoming workshop, starting May 9th, 2024, featuring Dr.
- Helix 8 in chemotactic receptors of the complement system
A comparison of microsecond MD trajectories started from active and inactive C5aR1 receptor conformations
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
early and sustained statistically significant reduction of symptoms, as assessed by PANSS total score, starting
- A broad look into the future of systemic sclerosis
The authors provide a hierarchical structure into the studies of the pathogenesis of SSc starting with
- Breaking the Myth of High and Low Affinity Sites
your work efficiently ✅ Clarity that helps you move from assay to decision faster, with fewer false starts
- 📰 GPCR Weekly News, April 22 to 28, 2024
Fill out this form to get started! Contact Mark today to get started.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
work on Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential Today, we started
- 📰 GPCR Weekly News, April 15 to 21, 2024
Fill out this form to get started! Contact Mark today to get started.
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development.
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted GPCR courses GPCR Forum Start GPCR Events You can start planning and save some dates in 2025 .
- Accelerating GPCR Drug Discovery
Why I Started GPCR Consulting You've got great data. You've got brilliant scientists.
- TeachOpenCADD - A teaching platform for computer-aided drug design
Beyond their teaching purpose, the TeachOpenCADD material can serve as starting point for users’ project-directed



















